The role of the NADPH oxidase NOX2 in prion pathogenesis

PLoS Pathog. 2014 Dec 11;10(12):e1004531. doi: 10.1371/journal.ppat.1004531. eCollection 2014 Dec.

Abstract

Prion infections cause neurodegeneration, which often goes along with oxidative stress. However, the cellular source of reactive oxygen species (ROS) and their pathogenetic significance are unclear. Here we analyzed the contribution of NOX2, a prominent NADPH oxidase, to prion diseases. We found that NOX2 is markedly upregulated in microglia within affected brain regions of patients with Creutzfeldt-Jakob disease (CJD). Similarly, NOX2 expression was upregulated in prion-inoculated mouse brains and in murine cerebellar organotypic cultured slices (COCS). We then removed microglia from COCS using a ganciclovir-dependent lineage ablation strategy. NOX2 became undetectable in ganciclovir-treated COCS, confirming its microglial origin. Upon challenge with prions, NOX2-deficient mice showed delayed onset of motor deficits and a modest, but significant prolongation of survival. Dihydroethidium assays demonstrated a conspicuous ROS burst at the terminal stage of disease in wild-type mice, but not in NOX2-ablated mice. Interestingly, the improved motor performance in NOX2 deficient mice was already measurable at earlier stages of the disease, between 13 and 16 weeks post-inoculation. We conclude that NOX2 is a major source of ROS in prion diseases and can affect prion pathogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Case-Control Studies
  • Cell Proliferation
  • Cerebellum / metabolism
  • Cerebellum / pathology
  • Creutzfeldt-Jakob Syndrome / metabolism
  • Creutzfeldt-Jakob Syndrome / pathology
  • Creutzfeldt-Jakob Syndrome / physiopathology*
  • Disease Models, Animal
  • Female
  • Frontal Lobe / metabolism
  • Frontal Lobe / pathology
  • Humans
  • Male
  • Membrane Glycoproteins / deficiency
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / physiology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microglia / metabolism
  • Microglia / pathology
  • NADPH Oxidase 2
  • NADPH Oxidases / deficiency
  • NADPH Oxidases / genetics
  • NADPH Oxidases / physiology*
  • Prion Diseases / metabolism
  • Prion Diseases / pathology
  • Prion Diseases / physiopathology*
  • Prions / physiology*
  • Reactive Oxygen Species / metabolism

Substances

  • Membrane Glycoproteins
  • Prions
  • Reactive Oxygen Species
  • CYBB protein, human
  • Cybb protein, mouse
  • NADPH Oxidase 2
  • NADPH Oxidases

Grants and funding

SS was supported by the Betty and David Koetser Award for Brain Research and a Roche post-doc fellowship; MN was supported by a fellowship from Collegio Ghislieri, Pavia and the Foundation for Research at the Medical Faculty of the University of Zurich, AA was supported by the European Union (PRIORITY; NEURINOX), the SNF (grant 31003A_141193), the Clinical Research Focus Program of the University of Zurich, the Foundation Alliance BioSecure, the Novartis Research Foundation, and an Advanced Grant of the European Research Council (grant 250356). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.